Boston, MA -- (SBWIRE) -- 01/24/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Green Plains Renewable Energy Inc.(NASDAQ:GPRE), Crocs, Inc.(NASDAQ:CROX), Thompson Creek Metals Company Inc (USA)(NYSE:TC), PDL BioPharma Inc.(NASDAQ:PDLI).
Green Plains Renewable Energy Inc.(NASDAQ:GPRE), opened its shares at the price of $22.16 for the day. Its closing price was $22.31after gaining0.95% for the day. The company traded with the total volume of 1.50 million shares, while its average trading volume remained 1.15 million shares. Green Plains Renewable Energy, Inc. engages in the production, marketing, and distribution of ethanol in the United States.
Will GPRE Continue To Move Higher? Find Out Here
Crocs, Inc.(NASDAQ:CROX), percentage change plunged -1.57% to close at $15.05 with the total traded volume of 1.48 million shares, and average volume of 1.88 million. The 52 week range of the stock remained $11.96 - $17.95.Crocs, Inc., together with its subsidiaries, engages in the design, manufacture, marketing, and distribution of footwear, apparel, and accessories for men, women, and children in the Americas, Europe, and Asia
-Will CROX Get Buyers Even After The Recent Rally? Find Out Here
Thompson Creek Metals Company Inc (USA)(NYSE:TC), started its trading session with the price of $2.73 and closed at $2.70 by scoring –2.88%. TC’s stocks traded with total volume of 1.48 million shares, while the average trading volume remained 2.18 million shares. Thompson Creek Metals Company Inc. engages in mining, milling, processing, and marketing of molybdenum products in the United States and Canada.
-Will TC Get Buyers Even After The Recent Rally? Find Out Here
PDL BioPharma Inc.(NASDAQ:PDLI) ended its day with the gain of 0.33% and closed at the price of $9.07 after opening at $9.03. Stock traded during its last trading session with the total volume of 1.47 million shares, as compared to its average volume of 2.20 million shares. PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions
Will PDLI Continue To Move Higher? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)